Atherosclerosis & treatment of CVD Flashcards

(39 cards)

1
Q

Risk factors for atherosclerosis

A
  1. smoking
  2. diabetes
  3. genetic (LDL receptors)
  4. endocrine (sex)
  5. hypertension
  6. hyperlipidaemia (raised LDL as opposed to HDL)
  7. oxidised LDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is LDL?

A

Sphere of phospholipids containing high concentrations of cholesterol and apo-B

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the function LDL?

A

Transport of water-soluble cholesterol in the blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What does PCSK9 do?

A

binding LDL receptors and promoting their intracellular degradation - could be targetted by anti-LDL antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How may LDL cause atherosclerosis (mechanism is unknown)?

A

thought LDL particles infiltrate the intima where they undergo modification that make the immunogenic, as well as proinflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How is HDL a risk factor? Discuss

A
  • low levels are a risk factor

- HDL is involved in transport from peripheral tissues back to the liver where it is excreted

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How may changes to the endothelial layer lead to atherosclerosis?

A
  • plaques tend to form at points of flow disturbance and endothelial sheer stress is partially responsible for the induction of an atherogenic endothelial phenotype
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Possible clinical manifestations of atherosclerosis

A
  • angina
  • MI
  • claudication (pain caused by too little blood flow to the legs and arms)
  • embolism
  • aneurysm
  • ischaemic stroke
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Is atherosclerosis more common in makes or females?

A

Males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What stages can the pathogenesis of atherosclerosis be considered in?

A
  1. LDL oxidation (due to endothelial injury or dysfunction)
  2. monocyte/ macrophage recruitment
  3. foam cell recruitment
  4. lesion progression
  5. plaque stability
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What do atherosclerotic lesions begin as and what is the major cellular event contributing to the formation of these structures?

A
  • They begin as fatty streaks underlying the endothelium of large arteries
  • uptake of LDL-derived cholesterol by macrophages
  • can be argued that oxidation of LDL is the main cellular event
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which vessels do plaques form in?

A

Absent from veins and the microvasculature

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why ox-LDL taken up by macrophages in particular?

A

It can no longer be recognised by LDL receptors on cells but is instead recognised by scavenger receptors found on surface of macrophages and SMCs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Discuss how endothelial dysfunction leads to monocyte recruitment

A
  • loss of protective effects of NO in particular
  • starts expressing a range of adhesion molecules which capture circulating monocytes
  • e.g. VCAM-1
  • E and P selectin
  • ICAM-1
  • oxLDL can also directly attract monocytes via the expression of monocyte chemotactic molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe platelet recruitment to endothelium

A

Endothelial erosion exposes collagen-rich prothombotic sub-endothelium, to which platelets adhere and form microthrombi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Aside from monocyte and platelet recruitment, what may endothelial injury cause?

A
  • generation of proatherogenic ET-1

- generation of superoxide (oxidising free radical)

17
Q

Describe the inflammation that occurs after endothelial injury

A
  • monocytes → macrophages → generate pro-oxidant species
  • platelets degranulate → release of pro-inflammatory mediators
  • SMCs begin to proliferate and for the ‘neointima’ in response to GFs and absence to anti-mitogenic NO
  • SMCs of neointima → become non-contractile and secrete ECM to stabilise developing plaque
18
Q

When do foam cells form?

A
  • caused by uptake of cholesterol by macrophages
19
Q

What is the transition from a fatty streak to a complex lesion characterised by?

A
  • Immigration of SMCs from the medial layer past the internal elastic lamina and into the sub-endothelial space
  • Intimal SMCs proliferation and take up modified lipoproteins, contributing to foam cell formation and synthesize ECM that leads to the development of the fibrous cap
20
Q

What forms the necrotic core of the apoptotic lesions?

A

SMCs and macrophages which have formed foam cells begin to apoptose and necrose

21
Q

What may happen in the plaque is unstable?

A
  • it may rupture

- can cause an ischaemic event

22
Q

What do statins do?

A

lower cholesterol by inhibiting HMG-CoA reductase and increase hepatic LDL-receptor expression
- leads to decreased plasma LDL-C and increased plasma triglycerides (and HDL)

23
Q

Aside from lowering LDL, what else may statins do?

A
  • restoration of healthy endothelium
  • anti-platelet effects
  • plaque stabilisation
24
Q

How to prevent CVD through lifestyle choices?

A
  • smoking
  • obesity
  • physical activity
  • blood pressure
  • diet
25
List some anti-thombotic and thrombolytic drugs drugs
- aspirin - GpIIb and IIIa inhibitors - strepokinase - tPA
26
List some anti-coagulant drugs
- heparin | - warfarin
27
List some lipid lowering drugs
Statins
28
Give examples of statins
simvastatin
29
Describe surgical intervention in treatment of CVD
- balloon angioplasty - stenting - coronary bypass
30
What is coronary bypass?
- surgery that redirects blood around a section of a block or partially blocked artery in your heart to improve blood flow to the heart muscle
31
Mechanism of action of aspirin
- inhibits COX which is required for prostagandin and thromboxane synthesis - prostaglandins are pro-inflammatory - thomboxanes promote clotting (inhibit platelet aggregation)
32
Mechanism of action of GpIIb and IIIa inhibitors
Prevent platelet aggregation and thrombus formation by inhibiting the GpIIb/IIIa receptor on the surface of platelets - this prevents binding of fibrinogen which blocks aggregation (GpIIb/IIIa receptors are on the surface of platelets and bind fibrinogen)
33
Mechanism of action of streptokinase
- fibrinolytic - binds with free circulating plasminogen (or plasmin) to form a complex that can convert additional plasminogen to plasmin - plasmin breaks down fibrin clots created by the blood clotting cascade
34
Mechanism of action of tPA
- tissue plasminogen activator 1. binds fibrin on the surface of the clot 2. activates fibrin-bound plasminogen 3. plasmin is cleaved from the plasminogen associated with the fibrin 4. fibrin molecules are broken apart by the plasmin and the clot dissolves
35
Example of tPA
Alteplase
36
Mechanism of action of heparin
Binds to enzyme inhibitor antithrombin III → activates it | ATIII inactivated thrombin (IIa)and factor Xa
37
Mechanism of action of warfarin
- acts to inhibit the vitamin K post-translational modification of clotting factors II, VII and IX and X - inhibits vitamin K reductase
38
How may action of warfarin be reversed?
- oral vitamin K supplementation
39
How may the action of heparin be reversed?
- protamine sulphate | - binds to heparin to form a stable ion pair with no anticoagulant activity